Cocaine (COC) antibody and antigen (hapten, BSA/OVA conjugated)

Diagnostic anti-Cocaine (COC) antibodies (anti-Cocaine, anti-COC) and diagnostic hapten-carrier conjugates BSA-Cocaine (COC), OVA-Cocaine (COC), KLH-Cocaine (COC) antigens for Inflammation/autoimmune/inflammatory disease COC detection in ELISA test, competitive ELISA, Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Inflammation/autoimmune/inflammatory disease diagnostics products collection>>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-227-Ag01BSA-Cocaine (COC)$756.00
GMP-SMT-227-Ag02OVA-Cocaine (COC)$756.00
GMP-SMT-227-Ab01Anti-human Cocaine (COC) mouse monoclonal antibody (mAb)$1953.00
GMP-SMT-227-Ab02Anti-human Cocaine (COC) human monoclonal antibody (mAb)$1953.00

Size: 1mg | 10mg | 100mg



Product Description

BSA-Cocaine (COC)

Cat No.GMP-SMT-227-Ag01
Product NameBSA-Cocaine (COC)
TargetCocaine (COC)
Expression platformSynthetic
Bioactivity validationCocaine (COC) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in COC level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Cocaine (COC) / OVA-Cocaine (COC) is Synthetic.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

OVA-Cocaine (COC)

Cat No.GMP-SMT-227-Ag02
Product NameOVA-Cocaine (COC)
TargetCocaine (COC)
Expression platformSynthetic
Bioactivity validationCocaine (COC) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in COC level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Cocaine (COC) / OVA-Cocaine (COC) is Synthetic.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Cocaine (COC) mouse monoclonal antibody (mAb)

Cat No.GMP-SMT-227-Ab01
Product NameAnti-human Cocaine (COC) mouse monoclonal antibody (mAb)
TargetCocaine (COC)
Expression platformhybridoma
IsotypesMouse IgG
Bioactivity validationCocaine (COC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cocaine (COC) antibodies in COC level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation.
TagmFc
Products descriptionAnti-human Cocaine (COC) mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology.
PurityHigh (TBD)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Anti-human Cocaine (COC) human monoclonal antibody (mAb)

Cat No.GMP-SMT-227-Ab02
Product NameAnti-human Cocaine (COC) human monoclonal antibody (mAb)
TargetCocaine (COC)
Expression platformhybridoma
IsotypesHuman IgG1
Bioactivity validationCocaine (COC) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Cocaine (COC) antibodies in COC level test of Inflammation/autoimmune/inflammatory disease and related syndrome evaluation.
TaghFc
Products descriptionAnti-human Cocaine (COC) mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO.
PurityPurity: ≥95% (SDS-PAGE)
ApplicationCompetitive immunoassay validation (Competitive ELISA), ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
FormulationSupplied as a 0.2 μM filtered solution of PBS, PH7.4.
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Target/Biomarker information


    Cocaine in In Vitro Diagnosis (IVD): Cocaine, a formidable stimulant drug, possesses a multifaceted role in both clinical and forensic spheres. Within the realm of in vitro diagnosis (IVD), Cocaine emerges as a pivotal target molecule for diagnostic assays, underpinning a broad array of applications. Our company, as a leading provider in the field, specializes in delivering specialized anti-Cocaine antibodies and small molecule competitive antigens, spanning a comprehensive spectrum that includes Carrier-coupled antigens, immunogens, hapten-carrier conjugates, Bovine Serum Albumin (BSA)-conjugated, and Ovalbumin (OVA)-conjugated variants. Each of these meticulously designed reagents is tailored to facilitate the precise and discerning detection of Cocaine across diverse sample matrices, ranging from clinical specimens to forensic samples.

    Significance of Measuring Cocaine:

    a. Therapeutic Drug Monitoring (TDM): Cocaine, while infrequently employed as a local anesthetic in select medical procedures, necessitates Therapeutic Drug Monitoring (TDM). TDM entails the vigilant monitoring of Cocaine levels within patients to ensure therapeutic efficacy while averting the potential perils associated with overdose or adverse reactions. By facilitating precise dosage adjustments, TDM enhances patient safety during medical interventions.

    b. Substance Abuse Detection: Cocaine misuse and addiction represent formidable challenges to public health and individual well-being. Accurate Cocaine measurement forms the cornerstone of substance abuse detection, enabling the timely identification of illicit drug use. This, in turn, empowers healthcare providers to initiate timely interventions and guide individuals toward specialized addiction treatment programs, ultimately mitigating the societal impact of substance abuse.

    c. Forensic Investigations: Cocaine testing assumes a pivotal role in forensic investigations, encompassing post-mortem examinations and drug-related criminal cases. The accurate detection and quantification of Cocaine within biological and non-biological specimens contribute significantly to the determination of cause of death, the establishment of legal causality, and the substantiation of criminal proceedings. Forensic laboratories rely extensively on Cocaine assays to unearth critical evidence and provide expert testimony.

    d. Occupational and Drug Screening: The workplace, with its emphasis on safety and productivity, mandates stringent drug screening protocols. Cocaine detection is integral to these occupational settings, ensuring the maintenance of a secure work environment. Employers rely on accurate Cocaine assays to enforce anti-drug policies and mitigate potential risks associated with impaired job performance due to substance use.

    e. Research and Development (R&D): Cocaine assays are of paramount importance in the realm of pharmaceutical Research and Development (R&D). These assays play a pivotal role in assessing the pharmacokinetics, metabolism, and pharmacodynamics of Cocaine and its derivatives. Researchers leverage Cocaine assays to inform drug design and development, particularly in the context of pain management, local anesthesia, and other clinical applications. These endeavors drive advancements in therapeutic outcomes and pharmaceutical innovation.

    In summation, the precise measurement of Cocaine assumes a paramount role that traverses a diverse spectrum of clinical, forensic, and research contexts. This span of relevance ranges from safeguarding patient safety during medical interventions to addressing the scourge of substance abuse, supporting legal investigations, upholding workplace integrity, and propelling pharmaceutical innovations. Our specialized anti-Cocaine antibodies and competitive antigens constitute indispensable tools in the arsenal of clinicians, diagnosticians, researchers, and forensic experts, enabling the accurate and sensitive detection of Cocaine and ultimately contributing to enhanced patient care, public health, and scientific progress.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.